Viewing nowHypertelmival 40 mg (Telmisartan)
Telmisartan 40mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.

MFDS item code 201500978 · Approved 2015.02.25 · Insurance code 649102640
Treatment of essential hypertension, prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication helps to control blood pressure in patients with essential hypertension and improve cardiovascular health. Additionally, in cases where ACE inhibitors cannot be used, it is effective in reducing the risk of myocardial infarction, stroke, and death due to cardiovascular disease in patients aged 55 and older with a high risk of cardiovascular disease. It is particularly useful in high-risk patients with coronary artery disease, peripheral artery disease, stroke, or diabetes. This drug may help prevent serious complications related to cardiovascular diseases. Therefore, it is actively used for hypertension management and reduction of cardiovascular disease risk.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is reached 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medication may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm or risk of death to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergic reactions, severely impaired liver function, pregnant or breastfeeding women, or patients with certain kidney diseases. Elderly patients or those with reduced kidney function, as well as patients with heart or vascular problems, should use this medication with caution and monitor their condition closely. Upon taking this medication, blood pressure may drop too low, or dizziness, fainting, etc. may occur, so if these symptoms appear, immediate consultation with medical staff is necessary. There is a risk of increased potassium levels in the blood, so patients at risk of hyperkalemia should have regular blood tests for monitoring. It can affect liver or kidney function, so periodic liver and kidney function tests are important during treatment. This medication may interact with other antihypertensives, diuretics, lithium, non-steroidal anti-inflammatory drugs (NSAIDs), etc., so it is crucial to inform your healthcare provider if you are taking other medications. Caution is needed when driving or operating hazardous machinery due to the risk of dizziness or fainting. This medication contains sorbitol, so individuals with fructose intolerance should avoid it. Pregnant women or those planning to become pregnant should not use this medication, and it is also recommended that breastfeeding women avoid it. Children under 18 years of age should not use this medication, as its safety and efficacy have not been established. In case of overdose, there is a risk of hypotension, dizziness, acute renal failure, etc., and immediate contact with medical personnel for appropriate treatment is necessary. This medication should be stored out of reach of children, and the package should not be opened until just before taking it.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering and kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain its effectiveness.
White or almost white, double-convex round tablets
30 tablets/blister [10 tablets/blister X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.